Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment (Q42705622)
Jump to navigation
Jump to search
scientific article published on 15 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment |
scientific article published on 15 May 2014 |
Statements
1 reference
Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment (English)
1 reference
Elena Lukina
1 reference
Nora Watman
1 reference
Marta Dragosky
1 reference
Gregory M Pastores
1 reference
Elsa Avila Arreguin
1 reference
Hanna Rosenbaum
1 reference
Ari Zimran
1 reference
Jennifer Angell
1 reference
Leorah Ross
1 reference
Ana Cristina Puga
1 reference
Judith M Peterschmitt
1 reference
15 May 2014
1 reference
1 reference
Identifiers
1 reference